Labshake search
Citations for Merck :
1 - 12 of 12 citations for VIP Antagonist since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... NMDA-antagonist MK801 (Merck KGaA, Germany) was added as a control at a concentration of 10 μM simultaneously to glutamate addition ...
-
bioRxiv - Developmental Biology 2023Quote: ... ERK antagonist PD 0325901 (1uM, PZ0162-5MG, Merck) and 1000 units/ml LIF diluted in N2B27 ...
-
bioRxiv - Neuroscience 2024Quote: ... and GABAA antagonist (Bicuculline; Merck Life Science UK Ltd, #14340) to the bath aCSF being perfused to the slice ...
-
bioRxiv - Clinical Trials 2019Quote: ... competitive angiotensin II type 1 receptor antagonist losartan (LT, Cozaar; Merck, USA) or placebo (PLC) ...
-
bioRxiv - Neuroscience 2024Quote: ... an NMDA receptor antagonist (DAP-5; Merck Life Science UK Ltd, #A8054) and GABAA antagonist (Bicuculline ...
-
bioRxiv - Immunology 2019Quote: ... anti-human C5aR or nonpeptide C5aR antagonist W-54011 (5 μM, Merck Millipore)(25 ...
-
bioRxiv - Developmental Biology 2020Quote: ... A GnRH antagonist (0.25 mg of Cetrorelix acetate, Cetrotide®, Merck Serono, Spain) was administered daily from day 6 of stimulation (for donors ...
-
bioRxiv - Molecular Biology 2019Quote: ... Ovarian hormonal stimulation was conducted according to the GnRH antagonist (Cetrotide, Merck Serono, Geneva, Switzerland) protocol with the administration of recombinant FSH (Gonal-F ...
-
bioRxiv - Immunology 2022Quote: ... approximately 5×105 Calu-3 cells were pre-treated with kp7-6 (100 ug/mL, CD95/CD95L antagonist, Merck) for 2 hour and then infected with SARS-CoV-2 at an MOI of 0.2 ...
-
bioRxiv - Cell Biology 2021Quote: ... Fixed daily doses of 0.25 mg of gonadotropin-releasing hormone (GnRH) antagonist (Orgalutran, Organon; Cetrotide, Merck Serono; or Fyremadel, Ferring) were started when the leading follicle reached a mean diameter of 13-14 mm ...
-
bioRxiv - Neuroscience 2024Quote: Blockade of synaptic ligand-gated ion channels was achieved by application of an AMPA receptor antagonist (NBQX; Merck Life Science UK Ltd, #N183), an NMDA receptor antagonist (DAP-5 ...
-
bioRxiv - Immunology 2020Quote: ... Ovarian stimulation was accomplished using a short protocol strategy combining gonadotropin releasing hormone antagonist (an-GnRH) short protocol (Cetrorelix acetate, Cetrotide, Merck Serono Europe Limited, Spain), recombinant FSH (Gonal-f 75 UI ...